NOVN Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 liep. 2023 @ 23:00):

Stats
Dzisiejszy wolumen	6.93M
Średni wolumen	1.04M
Kapitalizacja rynkowa	2.64M
EPS	$0 ( 2024-03-28 )
Następna data zysków	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.112
ATR14	$0.103 (183.93%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-27	Sanders Machelle	Sell	11 553	Common Stock
2023-06-06	John A. Donofrio	Buy	85 000	Restricted Stock Units
2023-06-06	Gay John M.	Buy	200 000	Restricted Stock Units
2023-06-07	Gay John M.	Buy	65 000	Common Stock
2023-06-06	Gay John M.	Buy	65 000	Restricted Stock Units

INSIDER POWER
60.85
Last 97 transactions
Buy: 4 746 863 \| Sell: 340 227

Wolumen Korelacja

Długi: -0.41 (neutral)

Krótki: -0.55 (weak negative)

Signal:(24.752) Neutral

Novan Inc Korelacja

10 Najbardziej pozytywne korelacje
ARKO	0.981
GLPG	0.962
SIRI	0.955
TTEC	0.953
CLOV	0.953
FOXF	0.95
HCDIP	0.943
WKSP	0.943
LPSN	0.942
SHEN	0.942

10 Najbardziej negatywne korelacje
VITL	-0.963
AEYE	-0.952
JAN	-0.945
TRMR	-0.943
ROOT	-0.942
PPC	-0.939
THRN	-0.938
CPTA	-0.936
VCTR	-0.936
RZLT	-0.935

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Novan Inc Korelacja - Waluta/Towar

-0.25
( neutral )

-0.78
( moderate negative )

0.00
( neutral )

-0.08
( neutral )

-0.49
( neutral )

0.85
( strong )

Novan Inc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$0

FY	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$0

FY	2022
Przychody:	$23.61M
Zysk brutto:	$16.23M (68.74 %)
EPS:	$-0.890

FY	2021
Przychody:	$2.96M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.740

Financial Reports:

No articles found.

Novan Inc

Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.